The Strategy Catalyst Dispatch
The Strategy Catalyst Dispatch brings healthcare strategy professionals into the room with leading health system executives to explore how innovation, clinical leadership, and enterprise strategy intersect. Designed for strategy executives, physician leaders, and healthcare innovators, the podcast offers actionable takeaways to help organizations drive both clinical and financial impact.
The Strategy Catalyst Dispatch
The Strategist in Brief: August 6, 2026
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
This week, our quarterly What's Next Digest offers four predictions on payer mix headwinds, 340B claims-data mandates, AI-enabled cyberattacks, and OpenEvidence's health system expansion.
This is the Strategist in Brief for August sixth, twenty twenty-six, your quick audio rundown of the top headlines from Strategy Catalyst's newsletter. Here's what strategy leaders should know this week. This week's edition is a little different. Instead of our usual news roundup, we're offering an executive summary of our quarterly What's Next Digest. Four provocative predictions about payer mix headwinds, three forty B rebates, cybersecurity, and clinical AI. Be sure to check out the full version on the web for the complete analysis. Prediction number one: the Affordable Care Act exchange-driven payer mix hit will keep deepening through the second half of 2026, And the for-profits full year guidance marks the trajectory the rest of the sector is on. Here's our call. The second half twenty-twenty six self-pay and bad debt hit could land harder than mid-year budgets assume. The question is whether it's in your fiscal year twenty-twenty seven budget or discovered against it Prediction number two. By the end of twenty twenty-six, more drug manufacturers will tie three forty-b pricing to their own claims data mandates and enforce by withholding discounts. The Health Resources and Services Administration will not force a reversal of these policies. Our call: health systems betting on a federal rescue for manufacturers' claims data mandates are likely to be disappointed. Regardless of whether it's a drug manufacturer-led process or a federal program, Hospitals will end up submitting claims data to access discounts they are statutorily owed. Prediction number three: the debate over the HIPAA security rule is a distraction from a more urgent reality. AI is about to enable vulnerability discovery and cyberattacks at a scale that health systems simply aren't ready for. Here's our call. New AI tools are creating a radically new cybersecurity world. Vulnerability discovery is scaling rapidly, while healthcare remains constrained by its ability to deploy fixes across complex clinical environments. By year-end, the board's cybersecurity question will be, "Of the vulnerabilities we've identified, how quickly can we remediate them? What is the plan for the ones we can't?" And prediction number four, Open Evidence will add three or more health system deployments by year-end while staying ad-supported and selective about which terms it agrees to. Here's our call. Clinicians aren't waiting for those deals. The individual clinician business associate agreements leave the system holding the liability while the vendor keeps the ad revenue. Every health system should make a deliberate choice: pursue enterprise integration, stand up a governed alternative like UpToDate or Doximity, or establish formal guardrails for continued use That concludes this week's edition of The Strategist in Brief. For the full analysis behind each of these predictions in the What's Next Digest, be sure to check out the complete version on the web at hmacademy.com. Thanks for listening.